By Tom Zanki ( February 23, 2015, 2:41 PM EST) -- Bristol-Myers Squibb Co. agreed on Monday to buy venture capital-backed startup Flexus Biosciences Inc., a privately held biotech firm developing cancer-fighting therapies, for up to $1.25 billion, upgrading its assets in the fast-growing field of immunotherapy....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.